Abstract
The report covers a forecast and an analysis of the transplant diagnostics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the transplant diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the transplant diagnostics market on a global level.
In order to give the users of this report a comprehensive view of the transplant diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the transplant diagnostics market by segmenting the market based on product type, application, technology, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. By product type, the global transplant diagnostics market is segmented into the instrument, software, and reagent. By application, this global market includes blood profile, HLA, and pathogen detection. By technology, the transplant diagnostics market is segmented into NGS, PCR, and Sanger sequencing. By end-user, this market is segmented into research laboratories and academic institutes, hospitals and transplant centers, and commercial service providers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries, such as the U.S., Canada, Germany, France, UK, Brazil, China, Japan, India, and Brazil.
Some key players of the global transplant diagnostics market include Bio-Rad Laboratories, Inc., Siemens Healthineers (Siemens AG), Becton, Dickinson, and Company, Immucor, Inc., Qiagen N.V., Illumina, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Agilent Technologies, among others.
The report segments the global transplant diagnostics market into:
Global Transplant Diagnostics Market: Product Type Analysis
Instrument
Software
Reagent
Global Transplant Diagnostics Market: Technology Analysis
NGS
PCR
Sanger Sequencing
Global Transplant Diagnostics Market: Application Analysis
Blood Profile
HLA
Pathogen Detection
Global Transplant Diagnostics Market: End-User Analysis
Research Laboratories and Academic Institutes
Hospitals and Transplant Centers
Commercial Service Providers
Global Transplant Diagnostics Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa